MedTrace Logo

Hospital Mortality in Patients Submitted to Pharmacoinvasive Strategy With Tenecteplase (TNK)

NCT01791764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2013-02-15

No results posted yet for this study

Summary

This study has the following objective:

To identify related factors to hospital mortality in patients with ST-segment elevation acute myocardial infarction submitted to pharmacoinvasive strategy within a structured healthcare network.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Felipe JA Falcao · Federal University of São Paulo

  • Claudia MR Alves, Doctor · Federal University of São Paulo

  • Antonio CC Carvalho · Federal University of São Paulo

  • Adriano HP Barbosa · Federal University of São Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791764 on ClinicalTrials.gov